Journal article
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies
Abstract
Rivaroxaban (BAY 59-7939) is an oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of venous thromboembolism (VTE). This analysis of pooled results from two phase II studies of rivaroxaban for VTE prevention after major orthopaedic surgery aimed to strengthen the conclusions of the individual studies. One study was conducted in patients undergoing total hip replacement (THR; N = 722), and one in patients …
Authors
Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK
Journal
Thrombosis and Haemostasis, Vol. 97, No. 06, pp. 931–937
Publisher
Thieme
Publication Date
2007
DOI
10.1160/th07-01-0055
ISSN
0340-6245